CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo†
Maria A. González-Carmona(University of Bonn), Volker Schmitz(University of Bonn), Annabelle Vogt(University of Bonn), A. Timmerman(University of Bonn), Elisabeth Sievers(Karolinska University Hospital), Miroslaw Kornek(University of Bonn), S Shabani(University of Bonn), Ingo G.H. Schmidt‐Wolf(University Hospital Bonn), Wolfgang H. Caselmann(Ministry for Environment, Agriculture, Conservation and Consumer Protection), Yildiz Yildiz(Landeskrankenhaus Feldkirch), Veronika Lukacs‐Kornek(University Hospital Bonn), Tilman Sauerbruch(University Hospital Bonn)
Cited by 67
Related Papers
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
|Fibrogenesis & Tissue Repair|2013|330
The tumour microenvironment and immune milieu of cholangiocarcinoma
|Liver International|2019|194